ProShares UltraShort Nasdaq Biotechnology

The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies. Under normal circumstances, the fund will obtain inverse leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified.

The current price of BIS ETF is 8.21 USD — it has increased by 1.90% in the past 24 hours. Watch BIS ETF price performance more closely on the advanced chart.

BIS ETF has increased by 0.77% in the past week, has decreased by -15.94% in the past month, and has decreased by -60.72% in the past year. See more data on BIS ETF chart.

As of 22 Apr 2026, the largest holdings include Amgen Inc, Gilead Sciences Inc, Vertex Pharmaceuticals Inc, Biogen Inc, Illumina Inc, Regeneron Pharmaceuticals Inc. See the full list of BIS ETF holdings.

The BIS ETF consists of 104 holdings, including Amgen Inc, Gilead Sciences Inc, Vertex Pharmaceuticals Inc and others. See the full list of BIS ETF holdings.

As of 22 Apr 2026, the BIS ETF consists of 104 holdings. See the full list of BIS ETF holdings.

The BIS ETF sectors include Basic Materials, Consumer Cyclical, Financial Services, Real Estate, Communication Services and more.

The easiest way to buy BIS ETF is through an online broker. Some of the popular names are Vanguard, Fidelity, Schwab. Simply open an account, follow the procedures, and start trading. Alternatively, you can practice trading ETFs on Profit.com in Playtrade Tournaments or choose a recommended broker to trade directly.